<?xml version="1.0" encoding="UTF-8"?>
<p>The initial immunosuppressive treatment is listed in 
 <xref ref-type="table" rid="T2">Table 2</xref>. Most of the patients maintained the immunosuppression with a calcineurin inhibitor; 16 (27%) of 60 changed the immunosuppressive regimen; 11 (18%) switched to an mTOR inhibitor.
</p>
